We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

East-West Hepatocellular Carcinoma Study Group

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01237132
First Posted: November 9, 2010
Last Update Posted: November 9, 2010
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
University of Milan
  Purpose
The current treatment guidelines of hepatocellular carcinoma (HCC) of the American and European Associations for the Study of Liver Disease are based on the Barcelona-Clinic-Liver-Cancer classification (BCLC), which does not recommend surgery in patients with large, multinodular and macrovascular invasive disease. The aim of this study was to investigate the role of hepatic resection in a large retrospective multicentric cohort of patients resected for HCC regardless of the BCLC indications.

Condition
Carcinoma, Hepatocellular

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Retrospective
Official Title: EAST-WEST HEPATOCELLULAR CARCINOMA STUDY GROUP

Further study details as provided by University of Milan:

Primary Outcome Measures:
  • Overall survival of resected patients for HCC
    The primary endpoint of the study was the overall survival of patients resected for HCC in any stage of the BCLC classification.


Secondary Outcome Measures:
  • Disease-free survival of resected patients for HCC
    The secondary endpoint was the disease-free survival of patients resected for HCC among the BCLC stages.


  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   Child, Adult, Senior
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Patients affected by HCC
Criteria

Inclusion Criteria:

  • clinical diagnosis of hepatocellular carcinoma
  • candidate to liver resection as a curative treatment

Exclusion Criteria:

  • uncertain diagnosis of hepatocellular carcinoma
  • uncertain follow-up data
  Contacts and Locations
No Contacts or Locations Provided
  More Information

Responsible Party: GUIDO TORZILLI MD, PHD, UNIVERSITY OF MILAN
ClinicalTrials.gov Identifier: NCT01237132     History of Changes
Other Study ID Numbers: HCC EWE
First Submitted: November 8, 2010
First Posted: November 9, 2010
Last Update Posted: November 9, 2010
Last Verified: December 2009

Additional relevant MeSH terms:
Carcinoma
Carcinoma, Hepatocellular
Neoplasms, Glandular and Epithelial
Neoplasms by Histologic Type
Neoplasms
Adenocarcinoma
Liver Neoplasms
Digestive System Neoplasms
Neoplasms by Site
Digestive System Diseases
Liver Diseases